ARCELLX SHARES UP 10% AFTER CO ANNOUNCES POSITIVE DATA FROM MID-STAGE TRIAL OF ITS CANCER THERAPY FOR MULTIPLE MYELOMA

Reuters · 1d ago

Please log in to view news